CD8A and carcinoma: Strategies to inhibit or disrupt the carcinoma cell glycocalyx, and in particular sialic acid expression (70–73), may serve critical roles in blocking siglec activation and promoting NKG2D activation by infiltrating CD8+ T cells as well as NK cells that may critically promote anti-tumor immunity in lung cancer.